first and foremost, page-6

Pigofsteel, thats already discounted we are talking about potential deals here with multiple global multi billion dollar companies , in multiple applications with potential for hundreds of millions, if not billions of units.

Personally i used a base case scenario. If i thought it was only worth the above i would not have invested in the first place, because as you say it needs risk discounted.

There was another thread recently i think it was by tryngin that brilliantly outlined just some of the applications and there potential worth. While again his numbers where not spot on, they showed the enormity of the "Potential" here with obj.

I would be silly to say it has any certainty, but i feel equally about any comments that say it has no hugely significant potential. It is a high risk play that could amount to absolutely nothing, but i think you have not researched it sufficiently if you discount its potential to the level some posters are saying.

Lets face it it almost break even just from the research funding in the trail stage. Not many biotechs can claim that.